A mapping for managers: open innovation for R&D intensive SMEs in the life sciences sector

被引:9
作者
Marangos, Stefanos [1 ]
Warren, Lorraine [2 ]
机构
[1] Bournemouth Univ, Dept Leadership Strategy & Org, Sch Business, Bournemouth, Dorset, England
[2] Massey Univ, Sch Management, Innovat & Entrepreneurship, Palmerston North, New Zealand
关键词
SME; CEOs; Strategies; Open innovation; Life sciences; R&D intensive; BIO-PHARMACEUTICAL INDUSTRY; INBOUND OPEN INNOVATION; HIGH-TECH SMES; ABSORPTIVE-CAPACITY; DRUG DISCOVERY; SMALL FIRMS; TECHNOLOGY; KNOWLEDGE; NETWORKS; PERFORMANCE;
D O I
10.1108/EJIM-12-2015-0133
中图分类号
F [经济];
学科分类号
02 ;
摘要
Purpose - The purpose of this paper is to examine what strategies the CEOs of research and development (R&D) intensive small/medium enterprises (SMEs) in the life sciences sector carry out in regard to open innovation (OI), as R&D costs continue to rise, placing pressure on innovation managers. Design/methodology/approach - A qualitative study was carried out, consisting of 30 semi-structured interviews with CEOs of small R&D intensive SMEs in the life sciences sector. The authors analysed the key factors identified by the CEOs in relation to their OI strategies. Findings - SMEs adopt a range of OI strategies and collaborations, subject to certain conditions. A multilevel mapping developed from the analysis connects actors to the wider domain, setting the outcomes of the research in context. Research limitations/implications - This qualitative study provides detailed understandings that could provide the basis for a wider quantitative study that would provide greater coverage of the sector, thus reinforcing the outcomes. Practical implications - The study will be relevant to practising CEOs who are considering the range of options offered by OI. Originality/value - While large firms are adopting OI strategies, less is known about the OI strategies developed in SMEs. The study addresses that gap. The life sciences context is also novel.
引用
收藏
页码:210 / 229
页数:20
相关论文
共 50 条
[41]   Open Innovation in R&D: Co-Patenting With Breakthrough Innovations in Pharma [J].
Maamari, Bassem E. ;
Osta, Alfred .
INTERNATIONAL JOURNAL OF KNOWLEDGE MANAGEMENT, 2022, 18 (01)
[42]   Is internal R&D a necessary condition to link open innovation and innovative performance? [J].
Costa, Joana ;
Gomes, Catarina ;
Linardi, Marcelo Augusto .
INNOVATION-ORGANIZATION & MANAGEMENT, 2025,
[43]   How R&D originality affects open innovation under knowledge spillovers? [J].
Wang, Zongjun ;
Jiang, Zhenyu .
EUROPEAN JOURNAL OF INNOVATION MANAGEMENT, 2020, 23 (04) :604-628
[44]   A Lack of Insight: An Experimental Analysis of R&D Managers' Decision Making in Innovation Portfolio Management [J].
Behrens, Judith .
CREATIVITY AND INNOVATION MANAGEMENT, 2016, 25 (02) :239-250
[45]   Formation conditions, innovation, and learning in R&D consortia [J].
Eisner, Alan B. ;
Rahman, Noushi ;
Korn, Helaine J. .
MANAGEMENT DECISION, 2009, 47 (5-6) :851-871
[46]   Post-Catch-Up Strategy for Medium-Sized South Korean Firms: Improving Technological Capabilities by Balancing R&D Intensity and Open Innovation [J].
Paik, Jiwon ;
Chang, Hyun Joon .
ENGINEERING MANAGEMENT JOURNAL, 2015, 27 (04) :164-176
[47]   R&D Collaborations and Product Innovation [J].
Un, C. Annique ;
Cuervo-Cazurra, Alvaro ;
Asakawa, Kazuhiro .
JOURNAL OF PRODUCT INNOVATION MANAGEMENT, 2010, 27 (05) :673-689
[48]   The role of partner communication on cooperative R&D between SMEs and public research institutes in Korea [J].
Kim, Byung Keun ;
Park, Seong Keun .
ASIAN JOURNAL OF TECHNOLOGY INNOVATION, 2015, 23 (03) :366-382
[49]   Intermediating R&D and Marketing Value Creation by Open Innovation [J].
Wang, S. ;
Chen, J. ;
Xie, F. .
2011 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT (IEEM), 2011, :1170-1174
[50]   A symbiosis dynamic analysis for collaborative R&D in open innovation [J].
Yang, Chia-Han ;
Shyu, Joseph Z. .
INTERNATIONAL JOURNAL OF COMPUTATIONAL SCIENCE AND ENGINEERING, 2010, 5 (01) :74-84